Skip to main content
. 2016 Feb 12;31(5):930–937. doi: 10.3904/kjim.2014.290

Table 1.

Baseline characteristics of AKI patients treated with CRRT

Characteristic Complete renal recovery (n = 36) Incompleterenal recovery (n = 20) p value
Age, yr 56.3 ± 15.2 66.4 ± 11.4 0.014
Male sex 23 (63.9) 9 (45.0) 0.171
Baseline condition
 Diabetes mellitus 11 (30.6) 4 (20.0) 0.393
 Hypertension 12 (33.3) 9 (45.0) 0.388
 Heart disease 8 (22.2) 8 (40.0) 0.158
 Others 7 (19.4) 3 (15.0) 0.677
AKI cause 0.167
 Ischemic ATN 14 (38.9) 12 (60.0)
 Infection-related ATN 11 (30.6) 6 (30.0)
 Others 11 (30.6) 2 (10.0)
CRRT duration, hr 87.8 ± 57.0 140.2 ± 78.9 0.006
Anuria duration, hr 56.28 ± 92.6 201.3 ± 219.8 0.001
Body mass index, kg/m2 23.2 ± 4.3 20.5 ± 3.1 0.071
Initial Hb, g/dL 11.2 ± 2.3 10.6 ± 2.8 0.420
Initial CRP, mg/dL 12.8 ± 11.9 10.9 ± 10.9 0.571
Initial Cr, mg/dL 3.7 ± 2.1 3.9 ± 2.2 0.801
Initial eGFR, mL/min/1.73 m2 21.1 ± 11.7 18.9 ± 11.7 0.502
Final Cr, mg/dL 0.9 ± 0.2 1.6 ± 0.6 < 0.001
Final eGFR, mL/min/1.73 m2 87.3 ± 23.0 42.9 ± 12.4 < 0.001
Average MAP, mmHg 90.0 ± 9.1 87.5 ± 10.2 0.346
Volume balance, mL 536.7 ± 4,155.2 100.6 ± 4,298.8 0.712

Values are presented as mean ± SD or number (%).

AKI, acute kidney injury; CRRT, continuous renal replacement therapy; ATN, acute tubular necrosis; Hb, hemoglobin; CRP, C-reactive protein; Cr, creatinine; eGFR, estimated glomerular filtration rate; MAP, mean arterial pressure.